While the
trial concluded that the optimal treatment for these patients is three cycles
of chemotherapy,methodologic concerns have led to continued debate
about the optimal duration of chemotherapy [1,9].While the risk of
recurrence for stage I patients is lower, when patients do recur, treatment
is palliative